These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4373143)

  • 21. Therapy of hypertensive hypertrophy.
    Motz W; Strauer BE
    Scand J Clin Lab Invest Suppl; 1989; 196():62-71. PubMed ID: 2530623
    [No Abstract]   [Full Text] [Related]  

  • 22. [Renin-angiotensin system and sympathetic nerve factors].
    Kaneko Y
    Saishin Igaku; 1967 May; 22(5):922-9. PubMed ID: 4294963
    [No Abstract]   [Full Text] [Related]  

  • 23. [Complication and prognosis in essential hypertension].
    Hiwada K; Imamura Y
    Nihon Rinsho; 1992 May; 50 Suppl():238-45. PubMed ID: 1387423
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic implications from clinical trials for the treatment of hypertension.
    Kaplan NM
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):22S-27S. PubMed ID: 3540225
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes in the renin-angiotensin-aldosterone system during graduated ergometric tests in patients with essential arterial hypertension and in normal controls].
    Marchezotti AV; Feldstein CA; Leber B; Burucúa JE; Vilches AM; Varela de Rodríguez J
    Rev Clin Esp; 1981 May; 161(3):145-8. PubMed ID: 7022582
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pathobiochemistry of essential hypertension].
    Distler A
    Verh Dtsch Ges Inn Med; 1980; 86():295-303. PubMed ID: 7013327
    [No Abstract]   [Full Text] [Related]  

  • 27. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract]   [Full Text] [Related]  

  • 28. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
    Coca A; Redón J
    Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of antihypertensive treatment on the clinical course of coronary disease].
    Sciomer S; Bandiera A; Dagianti A
    Cardiologia; 1995 Dec; 40(12 Suppl 1):249-54. PubMed ID: 8998723
    [No Abstract]   [Full Text] [Related]  

  • 31. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different patterns in essential hypertension and possible choice of antihypertensive drugs.
    Koster M
    Arch Int Pharmacodyn Ther; 1980; Suppl():227-32. PubMed ID: 6998396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New viewpoints on the treatment of hypersensitivity. With comments on the pathogenesis of essential hypertension].
    Werning C
    Med Klin; 1974 Jun; 69(25):1087-99. PubMed ID: 4602392
    [No Abstract]   [Full Text] [Related]  

  • 34. [Age-related changes in the renin-angiotensin-aldosterone system and the sympathetic nervous system in patients with essential hypertension].
    Nami R; Martinelli M; Panza F; Pavese G; Carletti F; Buracchi P; Lucani B; Pazzaglia A; Saia F; Gennari C
    Minerva Cardioangiol; 1993 Sep; 41(9):387-95. PubMed ID: 8259235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increased activity of the sympathetic nervous system and the possibilities for therapeutic influence].
    Soucek M; Nevrlka J; Rihácek I; Frána P; Plachý M
    Vnitr Lek; 2007 May; 53(5):554-9. PubMed ID: 17642445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arterial hypertension. Research, progress, hypotheses in the 1970's].
    Mancia G; Zanchetti A
    G Ital Cardiol; 1981; 11 Suppl 1():185-201. PubMed ID: 7035270
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effectiveness of the secondary prevention of arterial hypertension in patients with ischemic heart disease].
    Kolomiets VV; Kozelkova LI; Nosova TI
    Vrach Delo; 1988 Oct; (10):5-7. PubMed ID: 3218198
    [No Abstract]   [Full Text] [Related]  

  • 38. Managing geriatric hypertension: a brief review.
    Sowers JR
    Geriatrics; 1985 Mar; 40(3):63-6. PubMed ID: 3972249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Microalbuminuria is an early marker for increased morbidity and mortality].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.